RxDoctor Payments Data

Nancy Keeler

Physician Assistant · Merced, CANPI 1427100320

Payments from drug & device makers

$1,260in general payments, 2019–2025

Across 72 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$142
  • GSK$139
  • Biohaven Pharmaceutical Holding Company Ltd.$103
  • Lilly USA, LLC$100
  • Pfizer$94
  • Johnson & Johnson$76
  • plus $607 from 17 others

What the payments were for

  • Food & beverage$1,260100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,260 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide52$54,739
Levothyroxine Sodium129$1,698
Metoprolol Succinate96$1,601
Atorvastatin Calcium129$1,353
Albuterol Sulfate HfaAlbuterol Sulfate16$1,101
Montelukast Sodium56$841
Losartan Potassium65$679
Omeprazole42$654
Gabapentin23$608
Duloxetine Hcl12$583
Escitalopram Oxalate31$562
Pantoprazole Sodium32$561
Bupropion Hcl SrBupropion Hcl19$541
Famotidine35$533
Metformin Hcl ErMetformin Hcl41$532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$62$54,73952 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Merced

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →